# Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy

> **NCT00873782** · PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 16 (actual)

## Conditions studied

- Muscular Dystrophies
- Duchenne Muscular Dystrophy
- Becker Muscular Dystrophy
- Limb-Girdle Muscular Dystrophy

## Interventions

- **OTHER:** Retrograde high pressure transvenous perfusion with normal saline

## Key facts

- **NCT ID:** NCT00873782
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-03-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00873782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00873782, "Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00873782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*